Medicines (MDCO) Form 3 MEDICINES / Peter Wijngaard ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Wijngaard Peter

(Last) (First) (Middle)

C/O THE MEDICINES COMPANY

8 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/30/2019

3. Issuer Name and Ticker or Trading Symbol
MEDICINES CO /DE [ MDCO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Development Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right-to-buy)	(1)	02/01/2021	Common Stock	10,000	15.94	D
Stock Option (right-to-buy)	(2)	02/24/2022	Common Stock	17,500	22.04	D
Stock Option (right-to-buy)	(3)	03/01/2023	Common Stock	40,995	31.49	D
Stock Option (right-to-buy)	(4)	03/01/2024	Common Stock	23,639	30.55	D
Stock Option (right-to-buy)	(5)	03/01/2025	Common Stock	37,143	28.77	D
Stock Option (right-to-buy)	(6)	03/01/2026	Common Stock	42,539	33.04	D
Stock Option (right-to-buy)	(7)	03/01/2027	Common Stock	50,189	52.7	D
Stock Option (right-to-buy)	(8)	03/01/2028	Common Stock	18,000	33.27	D
Stock Option (right-to-buy)	(9)	03/01/2029	Common Stock	125,000	25.41	D

Explanation of Responses:

1. Remainder of a grant of 20,000 stock options made to the reporting person on February 1, 2011. The remaining option vested in forty-eight equal monthly installments ending February 1, 2015.

2. Grant made to the reporting person on February 24, 2012. The option vested in forty-eight equal monthly installments ending February 24, 2016.

3. Grant made to the reporting person on March 1, 2013. The option vested in forty-eight equal monthly installments ending March 1, 2017.

4. Grant made to the reporting person on March 1, 2014. The option vested in forty-eight equal monthly installments ending March 1,2018.

5. Grant made to the reporting person on March 1, 2015. The option vested in forty-eight equal monthly installments ending March 1, 2019.

6. Grant made to the reporting person on March 1, 2016. The option vests in forty-eight equal monthly installments beginning April 1, 2016.

7. Grant made to the reporting person on March 1, 2017. The option vests in forty-eight equal monthly installments beginning April 1, 2017.

8. Grant made to the reporting person on March 1, 2018. The option vests in forty-eight equal monthly installments beginning April 1, 2018.

9. Grant made to the reporting person on March 1, 2019. The option vests in forty-eight equal monthly installments beginning April 1, 2019.

	/s/ Stephen M. Rodin, Attorney-in-Fact for Peter Wijngaard	06/07/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.